{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:45:57Z","timestamp":1791319557006,"version":"4.3.1"},"publisher-location":"Cham","reference-count":20,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319420424","type":"print"},{"value":"9783319420448","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-42044-8_1","type":"book-chapter","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T06:53:20Z","timestamp":1476687200000},"page":"3-8","source":"Crossref","is-referenced-by-count":39,"title":["Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer"],"prefix":"10.1007","author":[{"given":"Xiaodan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Milde-Langosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Trillsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Schwarzenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"1_CR1","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003\u20135008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233","journal-title":"Cell"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Sevignani C, Dumitru CD et al (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101:2999\u20133004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR4","doi-asserted-by":"crossref","unstructured":"Chen D, Dang BL, Huang JZ et al (2015) MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1alpha-TWIST signaling axis in breast cancer. Oncotarget, Epub of print","DOI":"10.18632\/oncotarget.4702"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1373\/clinchem.2013.205161","volume":"59","author":"C Eichelser","year":"2013","unstructured":"Eichelser C, Flesch-Janys D, Chang-Claude J et al (2013) Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin Chem 59:1489\u20131496","journal-title":"Clin Chem"},{"key":"1_CR6","doi-asserted-by":"crossref","first-page":"9650","DOI":"10.18632\/oncotarget.2520","volume":"5","author":"C Eichelser","year":"2014","unstructured":"Eichelser C, Stuckrath I, Muller V et al (2014) Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget 5:9650\u20139663","journal-title":"Oncotarget"},{"key":"1_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","volume":"114","author":"X Hu","year":"2009","unstructured":"Hu X, Macdonald DM, Huettner PC et al (2009) A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol 114:457\u2013464","journal-title":"Gynecol Oncol"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson GC, Kohn EC, Kitchener HC et al (2014) Ovarian cancer. Lancet 384:1376\u20131388","journal-title":"Lancet"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/1471-2407-12-627","volume":"12","author":"CW Kan","year":"2012","unstructured":"Kan CW, Hahn MA, Gard GB et al (2012) Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. BMC Cancer 12:627","journal-title":"BMC Cancer"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2014.05.022","volume":"351","author":"M Koutsaki","year":"2014","unstructured":"Koutsaki M, Spandidos DA, Zaravinos A (2014) Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics. Cancer Lett 351:173\u2013181","journal-title":"Cancer Lett"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","volume":"11","author":"J Krol","year":"2010","unstructured":"Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597\u2013610","journal-title":"Nat Rev Genet"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00404-013-3114-3","volume":"289","author":"I Meinhold-Heerlein","year":"2014","unstructured":"Meinhold-Heerlein I, Hauptmann S (2014) The heterogeneity of ovarian cancer. Arch Gynecol Obstet 289:237\u2013239","journal-title":"Arch Gynecol Obstet"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-014-3079-3","volume":"147","author":"V Muller","year":"2014","unstructured":"Muller V, Gade S, Steinbach B et al (2014) Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial. Breast Cancer Res Treat 147:61\u201368","journal-title":"Breast Cancer Res Treat"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"16833","DOI":"10.3390\/ijms160816833","volume":"16","author":"GG Muralidhar","year":"2015","unstructured":"Muralidhar GG, Barbolina MV (2015) The miR-200 family: versatile players in epithelial ovarian cancer. Int J Mol Sci 16:16833\u201316847","journal-title":"Int J Mol Sci"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3892\/ijo.2013.1896","volume":"42","author":"H Nakano","year":"2013","unstructured":"Nakano H, Yamada Y, Miyazawa T et al (2013) Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells. Int J Oncol 42:1875\u20131882","journal-title":"Int J Oncol"},{"key":"1_CR16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","volume":"22","author":"SM Park","year":"2008","unstructured":"Park SM, Gaur AB, Lengyel E et al (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22:894\u2013907","journal-title":"Genes Dev"},{"key":"1_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4939-1062-5_12","volume":"1182","author":"S Rani","year":"2014","unstructured":"Rani S (2014) MicroRNA profiling of exosomes isolated from biofluids and conditioned media. Methods Mol Biol 1182:131\u2013144","journal-title":"Methods Mol Biol"},{"key":"1_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach H, Nishida N, Calin GA et al (2014) Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol 11:145\u2013156","journal-title":"Nat Rev Clin Oncol"},{"key":"1_CR19","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","volume":"103","author":"L Zhang","year":"2006","unstructured":"Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR et al (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A 103:9136\u20139141","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR20","doi-asserted-by":"crossref","first-page":"12291","DOI":"10.18632\/oncotarget.2577","volume":"5","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Zhao FJ, Chen LL et al (2014) MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Oncotarget 5:12291\u201312303","journal-title":"Oncotarget"}],"container-title":["Advances in Experimental Medicine and Biology","Circulating Nucleic Acids in Serum and Plasma \u2013 CNAPS IX"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-42044-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T13:42:19Z","timestamp":1568468539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-42044-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319420424","9783319420448"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-42044-8_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}